FDA approves Lemtrada, the Drug that Fights Multiple Sclerosis Relapse

November 16, 2014 12:37 PM

14 0

Lemtrada, the drug fighting against multiple sclerosis relapse has been approved by Food and Drug Administration (FDA) and will be marketed in the US market. The drug has already been approved by the European Medicines Agency and has been declared safe for usage inside Australia, Canada and the European Union.

This drug was supposed to go in the US market in December last year but the same did not happen as the FDA rejected the drug because of the ample number of health risks associated with the consumption of this drug.

Read more

To category page